Mebendazole Export Market Intelligence: India's 259 Suppliers Shipping to 108 Countries — TransData Nexus 2026

Q: Who are the top mebendazole exporters from India?

The top mebendazole exporters from India are: 1. KROSYL PHARMACEUTICALS PRIVATE LIMITED — $2.7M (19.7% market share); 2. CADILA PHARMACEUTICALS LIMITED — $2.7M (19.6% market share); 3. LINCOLN PHARMACEUTICALS LTD — $1.2M (8.5% market share); 4. J B CHEMICALS AND PHARMACEUTICALS LIMITED — $539.7K (3.9% market share); 5. PRASHI PHARMA PRIVATE LIMITED — $398.2K (2.9% market share). Together they account for 54.5% of India's total mebendazole export value.

Q: What is the total export value of mebendazole from India?

The total export value of mebendazole from India is $13.7M USD, recorded across 2,932 shipment transactions from 259 active exporters to 108 destination countries. The average shipment value is $4.7K.

Q: Which countries import mebendazole from India?

India exports mebendazole to 108 countries worldwide. The top importing countries are: CAMEROON (22.4% share, $3.1M), FRANCE (14.3% share, $2.0M), SOUTH AFRICA (8.8% share, $1.2M), SRI LANKA (5.2% share, $717.0K), CONGO DR (4.9% share, $679.9K). These five markets account for 55.7% of total export value.

Q: What is the HS code for mebendazole exports from India?

The primary HS code for mebendazole exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of mebendazole exports from India?

The average unit price for mebendazole exports from India is $2.74 USD per unit, with prices ranging from $0.00 to $299.22 depending on formulation, packaging, and order volume. The total market is valued at $13.7M across 2,932 shipments.

Q: Which ports handle mebendazole exports from India?

The primary ports for mebendazole exports from India are SAHAR AIR CARGO ACC (INBOM4) (17.5% of shipments), SAHAR AIR (15.3% of shipments), NHAVA SHEVA SEA (INNSA1) (10.2% of shipments), DELHI AIR CARGO ACC (INDEL4) (9.9% of shipments), JNPT/ NHAVA SHEVA SEA (5.8% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of mebendazole?

India is one of the world's leading exporters of mebendazole due to its large base of 259 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports mebendazole to 108 countries, demonstrating 55% global market coverage.

Q: What certifications do Indian mebendazole exporters need?

Indian mebendazole exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import mebendazole from India?

There are 756 registered buyers importing mebendazole from India, spread across 108 countries. The repeat buyer rate is 38.4%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top mebendazole supplier from India?

KROSYL PHARMACEUTICALS PRIVATE LIMITED is the leading mebendazole exporter from India with a market share of 19.7% and total export value of $2.7M across 3 shipments. The top 5 suppliers together control 54.5% of total export value.

Suresh Sormare

Mebendazole

India Pharmaceutical Trade Intelligence

$13.7M259 Suppliers108 CountriesHS 30049099

ExportsIndia → CAMEROON22.4%India → FRANCE14.3%

ImportsUNITED STATES → India$347.0K ISRAEL → India$34.0K

#1 Supplier: KROSYL PHARMACEUTICALS #1 Buyer: PLANET PHARMA

Mebendazole Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Mebendazole to the World

Between 2022 and 2026, India exported $13.7M worth of mebendazole across 2,932 verified shipments to 108 countries — covering 55% of world markets in the Antimalarial & Antiparasitic segment. The largest destination is CAMEROON (22.4%). KROSYL PHARMACEUTICALS PRIVATE LIMITED leads with a 19.7% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026

Mebendazole export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Mebendazole export data snapshot — $13.7M · 259 exporters · 108 countriesTransData Nexus · Indian Customs Data

Top Mebendazole Exporters from India

259 active exporters · Ranked by export value

View all 259 →

Top Mebendazole Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	KROSYL PHARMACEUTICALS PRIVATE LIMITED	$2.7M	3	1	19.7%
2	CADILA PHARMACEUTICALS LIMITED

Top Countries Importing Mebendazole from India

108 destination markets · Ranked by import value

All 108 countries →

Top Countries Importing Mebendazole from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	CAMEROON	$3.1M	22.4%
2	FRANCE	$2.0M	14.3%
3	SOUTH AFRICA	$1.2M	8.8%
4	SRI LANKA	$717.0K	5.2%
5	CONGO DR	$679.9K	4.9%
6	ETHIOPIA	$577.9K	4.2%
7	AUSTRALIA	$479.1K	3.5%
8	ANGOLA	$343.5K	2.5%
9	TANZANIA	$333.8K	2.4%
10	COTE D IVOIRE	$304.4K	2.2%

CAMEROON is India's largest mebendazole export destination, absorbing 22.4% of total exports worth $3.1M. The top 5 importing countries — CAMEROON, FRANCE, SOUTH AFRICA, SRI LANKA, CONGO DR — together account for 55.7% of India's total mebendazole export value. The remaining 103 destination countries collectively receive the other 44.3%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Mebendazole to India?

9 origin countries · Total import value: $397.1K

India imports mebendazole from 9 countries with a combined import value of $397.1K. The largest supplier is UNITED STATES ($347.0K, 23 shipments), followed by ISRAEL and UNITED KINGDOM. All values are from Indian Customs (DGFT) import records.

Countries Supplying Mebendazole to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	UNITED STATES	$347.0K	23	87.4%
2	ISRAEL	$34.0K	2	8.6%
3	UNITED KINGDOM	$8.1K	1	2.0%
4	PORTUGAL	$4.0K	37	1.0%
5	GERMANY	$2.4K	2	0.6%
6	CANADA	$1.3K	1	0.3%
7	SOUTH AFRICA	$182	3	0.0%
8	BELGIUM	$169	1	0.0%
9	NETHERLANDS	$32	2	0.0%

UNITED STATES is the largest supplier of mebendazole to India, accounting for 87.4% of total import value. The top 5 origin countries — UNITED STATES, ISRAEL, UNITED KINGDOM, PORTUGAL, GERMANY — together supply 99.6% of India's mebendazole imports. Click any country to see detailed supplier and buyer data for that import corridor.

Mebendazole — Export Intelligence Video

Visual overview of India's mebendazole import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's mebendazole pharmaceutical import and export market — $13.7M in total trade, 259 verified manufacturers, and 108 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Mebendazole

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, mebendazole is approved for the treatment of various parasitic infections. The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for mebendazole, indicating a competitive generic market. Notably, on November 22, 2022, the FDA granted orphan drug designation to mebendazole for the treatment of autosomal dominant polycystic kidney disease, as per the FDA's Orphan Drug Designations and Approvals database. This designation provides incentives for the development of drugs for rare diseases.

Regarding import alerts, as of March 2026, there are no specific FDA import alerts related to mebendazole. However, the FDA maintains general import alerts for various countries and products, which are subject to change based on compliance and safety concerns. Exporters should regularly consult the FDA's Import Alert database to ensure compliance with current regulations.

2EU & UK Regulatory Framework

In the European Union, mebendazole is authorized for use in treating parasitic infections. The European Medicines Agency (EMA) maintains a list of nationally authorized medicinal products containing mebendazole, as detailed in their document published on January 15, 2026. This list provides comprehensive information on the marketing authorizations granted by individual EU member states.

In the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) oversees the authorization of medicinal products, including mebendazole. Manufacturers and exporters must comply with the UK's regulatory requirements, which include obtaining marketing authorization and adhering to Good Manufacturing Practice (GMP) standards.

3WHO Essential Medicines & Global Standards

Mebendazole is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its importance in treating parasitic infections globally. The WHO's Prequalification Programme ensures that medicines meet global standards of quality, safety, and efficacy. Additionally, mebendazole is recognized in various pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), reflecting its widespread acceptance and standardized quality parameters.

4India Regulatory Classification

In India, mebendazole is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription drug requiring a doctor's prescription for dispensation. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines; however, as of March 2026, mebendazole is not listed under the Drugs (Prices Control) Order (DPCO), implying no ceiling price is currently imposed. For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) for certain pharmaceutical products. Exporters should verify the latest DGFT notifications to determine if mebendazole requires an export NOC.

5Patent & Exclusivity Status

Mebendazole's primary patents have expired, allowing for the production and marketing of generic versions. The presence of multiple approved ANDAs in the FDA's Orange Book indicates a competitive generic market. The orphan drug designation granted in November 2022 for a new indication (autosomal dominant polycystic kidney disease) may provide market exclusivity for that specific use upon approval.

6Recent Industry Developments

In December 2022, the European Medicines Agency (EMA) granted orphan designation to mebendazole for the treatment of autosomal dominant polycystic kidney disease, as per the EMA's official records. This designation aims to encourage the development of drugs for rare diseases by providing incentives such as market exclusivity.

In January 2026, the EMA published a comprehensive list of nationally authorized medicinal products containing mebendazole, providing updated information on its regulatory status across EU member states. This publication serves as a valuable resource for stakeholders seeking detailed information on mebendazole's approval status within the EU.

These developments highlight the ongoing regulatory activities and the potential expansion of mebendazole's therapeutic applications beyond its traditional use as an anthelmintic.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Mebendazole

Retail & reference prices across 3 markets vs. India FOB export price of $2.74/unit

Global Price Benchmark for Mebendazole across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
Nigeria	Approximately $0.88 per tablet	NGN	According to the National Health Insurance Scheme (NHIS) Medicine Price List, the price for a 500mg Mebendazole tablet is 350.00 NGN. (cdn.who.int)
Kenya	Approximately $0.87 to $0.97 per 400mg tablet	KES	Information provided by Dr. Eberhard Zeyhle in October 2020 indicates that generic Albendazole 400mg tablets cost between 87.00 KES and 97.00 KES. (cdn.who.int)
IndiaORIGIN	Approximately $0.30 per 400mg tablet	INR	Locally produced Albendazole 400mg tablets are priced between 18.00 and 20.00 INR, as per information provided by Dr. Hameed Nuru in October 2020. (cdn.who.int)

Supply Chain Risk Assessment — Mebendazole

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

Mebendazole, an anthelmintic medication, is primarily produced in India, which has established itself as a significant hub for Active Pharmaceutical Ingredient (API) manufacturing. However, the production of APIs like mebendazole is heavily reliant on Key Starting Materials (KSMs), many of which are imported from China. This dependency poses a substantial risk, as any disruption in the supply of KSMs can halt API production. According to the U.S. Pharmacopeia, 58% of KSMs used for U.S.-approved APIs are sourced from a single country, with 41% from China and 16% from India.

Recent geopolitical tensions have exacerbated this vulnerability. In February 2026, the escalation of the U.S.-Iran conflict led to significant disruptions in the Strait of Hormuz, a critical maritime corridor for global trade. These disruptions have affected the transportation of raw materials, including KSMs, thereby impacting API production timelines and costs.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five Indian exporters of mebendazole account for 54.5% of total exports, with KROSYL PHARMACEUTICALS PRIVATE LIMITED leading at 19.7%. This concentration suggests a moderate risk, as reliance on a limited number of suppliers can lead to supply chain disruptions if any of these entities face operational challenges.

Access Complete Mebendazole Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 2,932 transactions across 108 markets.

Request Demo View Pricing

Frequently Asked Questions — Mebendazole Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top mebendazole exporters from India?

The leading mebendazole exporters from India are KROSYL PHARMACEUTICALS PRIVATE LIMITED, CADILA PHARMACEUTICALS LIMITED, LINCOLN PHARMACEUTICALS LTD, and 12 others. KROSYL PHARMACEUTICALS PRIVATE LIMITED leads with 19.7% market share ($2.7M). The top 5 suppliers together control 54.5% of total export value.

What is the total export value of mebendazole from India?

The total export value of mebendazole from India is $13.7M, recorded across 2,932 shipments from 259 active exporters to 108 countries. The average shipment value is $4.7K.

Which countries import mebendazole from India?

India exports mebendazole to 108 countries. The top importing countries are CAMEROON (22.4%), FRANCE (14.3%), SOUTH AFRICA (8.8%), SRI LANKA (5.2%), CONGO DR (4.9%), which together account for 55.7% of total export value.

What is the HS code for mebendazole exports from India?

The primary HS code for mebendazole exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Mebendazole

Mebendazole

Top Mebendazole Exporters from India

Top Countries Importing Mebendazole from India

Who Supplies Mebendazole to India?

Quick Facts

Related Antimalarial & Antiparasitic

Related Analysis

Need Details?

Mebendazole — Export Intelligence Video

Regulatory Landscape — Mebendazole

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Mebendazole

Supply Chain Risk Assessment — Mebendazole

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Mebendazole Trade Intelligence

Frequently Asked Questions — Mebendazole Exports from India

Who are the top mebendazole exporters from India?

What is the total export value of mebendazole from India?

Which countries import mebendazole from India?

What is the HS code for mebendazole exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of mebendazole exports from India?

Which ports handle mebendazole exports from India?

Why is India a leading exporter of mebendazole?

What certifications do Indian mebendazole exporters need?

How many buyers import mebendazole from India?

What is the market share of the top mebendazole exporter from India?

Analysis Methodology